GlycoNex Inc (4168)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GlycoNex Inc (4168) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014275
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through various technology platforms such as glycosphingolipid antigen production and identification, cancer drug screening, monoclonal antibody production, stable cell line production for monoclonal antibody and pharmacokinetics assessment. It provides glycobind antibody reagents. GlycoNex offers services such as functional evaluation, antibody engineering and antibody characterization. The company has an antibody bank that acts as a resource for future drug development. GlycoNex is headquartered in New Taipei City, Taiwan.

GlycoNex Inc (4168) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GlycoNex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GlycoNex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 10
Equity Offering 11
GlycoNex Announces Private Placement of Shares 11
GlycoNex Completes Public Offering Of Shares For US$3 Million 12
GlycoNex Raises USD24 Million in Rights Offering of Shares 13
GlycoNex Announces Private Placement Of Shares For US$9.2 Million 14
GlycoNex Completes IPO 15
Debt Offering 16
GlycoNex Announces Public Offering Of Bonds Due 2016 For US$10 Million 16
GlycoNex Inc – Key Competitors 17
GlycoNex Inc – Key Employees 18
GlycoNex Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
GlycoNex Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GlycoNex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GlycoNex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
GlycoNex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 10
GlycoNex Announces Private Placement of Shares 11
GlycoNex Completes Public Offering Of Shares For US$3 Million 12
GlycoNex Raises USD24 Million in Rights Offering of Shares 13
GlycoNex Announces Private Placement Of Shares For US$9.2 Million 14
GlycoNex Completes IPO 15
GlycoNex Announces Public Offering Of Bonds Due 2016 For US$10 Million 16
GlycoNex Inc, Key Competitors 17
GlycoNex Inc, Key Employees 18

★海外企業調査レポート[GlycoNex Inc (4168)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Teachers Mutual Bank Limited:企業の戦略的SWOT分析
    Teachers Mutual Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Premier Oil Plc (PMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Premier Oil Plc (Premier Oil) is an independent upstream oil and gas company. It explores for, develops and produces crude oil and natural gas. The company has interests in the North Sea, South East Asia, Pakistan, the Falkland Islands and Latin America. It explores under-explored proven hyd …
  • Honshu Chemical Industry Co Ltd (4115):企業の財務・戦略的SWOT分析
    Honshu Chemical Industry Co Ltd (4115) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Indian Oil Corp Ltd (IOC):石油・ガス:M&Aディール及び事業提携情報
    Summary Indian Oil Corp Ltd (IOCL) is an integrated oil and gas company that carries out exploration and production of oil and natural gas, refining of crude oil, pipeline transportation and marketing of natural gas and petroleum products. The company also produces and markets petrochemicals and has …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Biotest AG (BIO)-製薬・医療分野:企業M&A・提携分析
    Summary Biotest AG (Biotest) is a provider of pharmaceutical and biotherapeutic drugs which develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin an …
  • Applied Industrial Technologies, Inc.:企業のM&A・事業提携・投資動向
    Applied Industrial Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Applied Industrial Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • SPAGO Nanomedical AB-医療機器分野:企業M&A・提携分析
    Summary Spago Nanomedical AB (SPAGO Nanomedical), formerly SPAGO Imaging AB is a drug company that develops proprietary magnetic resonance imaging contrast agent, and the novel therapeutic project tumorad for cancer selective radionuclide treatment. The company concentrates on research and developme …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Lundin Mining Corporation:企業のM&A・事業提携・投資動向
    Lundin Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lundin Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cox & Kings Limited:企業の戦略・SWOT・財務分析
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kronos Incorporated:企業の戦略・SWOT・財務情報
    Kronos Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kronos Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cardiff University-製薬・医療分野:企業M&A・提携分析
    Summary Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of enginee …
  • Sonoro Energy Ltd (SNV):企業の財務・戦略的SWOT分析
    Summary Sonoro Energy Ltd (Sonoro Energy), formerly Sonic Technology Solutions Inc is an oil and gas company that explores, develops and produces asphalt and bitumen resources. It operates Budong Budong Production Sharing Contract on the coast of western Sulawesi, opposite to Balikpapan that offers …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務情報
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆